News About: Pharm. Industry
Eun-chul Hu and Man-hoon Park has seated in new chairs… Who will be the next CEOs expiring in contracts?
As the season of human affairs came back again this year, movements of chief executives in pharmaceutical companies has already been made while the industry also paid attention on future plans of those who will be exp...
Although the government tightened rebate regulations, listed pharmaceutical companies increased reception expenses
Official reception expenses of listedpharmaceutical companies have been increased.
According to the YakupDotCom’s analysis result of quarterly reports turned in to the Financial Supervisory Service from listed pharma...
Debt ratios of 13 pharmaceutical companies went over 100%
Since it is known that debt ratios of 13 listed pharmaceutical companies, such as Kyung Nam Pharm with a 324% debt ratio, are over 100%, the industry criticized on stability of its financial structure.
According to t...
“Please leave the company if you are over the age of the chairman”…Multinational pharmaceutical companies are asking for voluntary retirement
Multinational pharmaceutical companies branched in the Korean market are asking their employees for voluntary resignation, again this year.
According to the industry concerned on the 8th, 3 companies, Janssen Korea, ...
The pharmaceutical industry started to run the ‘Emergency Management’ due to the year-end rebate terror
As an enormous amount of rebates of Dong Wha Pharm has been exposed, strict investigation in the pharmaceutical industry is expected.
While the National Tax Service has not finished investigating cases with a leading...
Advanced notices sent out to 1,900 doctors…controversial noise made in the pharmaceutical industry
As the Ministry of Health and Welfare sent advanced rebate disposal notices to 1,900 doctors, it has been noisy in the pharmaceutical industry.
Pharmacists are paying attention on the notices because they might cause...
“Pfizer Korea, tried to illegally lobby, needs to get thoroughly inspected”
It is noticed that the Health Insurance Review & Assessment Service (HIRA) stood by and watch Pfizer Korea make illegal lobbying to the Price Evaluation Committee.
The Health Insurance Subscribers’Forum, on the 4th, ...
Korea Biochem Pharm has passed the actual inspection of TEVA on component manufacturing facilities
Korea Biochem Pharm, a branch of Korea United Pharm (president Duk-young Kang), has passed an actual inspection of TEVA on manufacturing facilities.
As making a contract with an Israel global pharmaceutical company, ...
Multinational pharmaceutical companies’ partnerships with domestic companies… what are advantages?
Product cooperation has been widely spread between multinational pharmaceutical companies and domestic pharmaceutical companies in Korea. The partnership has generated an effect of cutting off competition as well as n...
The start-up plantoenter the top fifth in the clinical trial market worth of KRW 72 trillion
The Korea National Enterprise for Clinical Trials (chairman Dong-hyunJi, KoNECT) will push ahead with a project to accomplish its vision for the ‘Top Fifth on Clinical Trials by 2020’.
The KoNECTannounced the new vis...
